No Picture
Trading Ideas

Moderna Pops 15% On FDA Approval For Phase 2 Covid-19 Vaccine Trial

Moderna (MRNA) has announced that the FDA has completed its review of the company’s Investigational New Drug (IND) application for its novel coronavirus vaccine candidate (mRNA-1273).The FDA will now allow the vaccine to proceed to a Phase 2 study, which is expected to begin shortly, Moderna revealed. Shares are surging 15% in Thursday’s pre-market trading, with the stock already recording a whopping 150% year-to-date gain.Looking further ahead, the company is also finalizing the protocol for the Phase 3 study of mRNA-1273, which is expected to begin in early summer of 2020.“The imminent Phase 2 study start is a crucial step …read more […]

No Picture
Business News

Apple awards $10 million to nasal swab maker COPAN Diagnostics to help boost factory output

Apple Inc said on Thursday that it was awarding $10 million to a maker of nasal swabs and other materials for collecting samples for Covid-19 tests in a move aimed at boosting the swab maker’s production to 1 million collection kits per week by early July.

…read more […]

No Picture
Trading Ideas

JetBlue reports loss, revises Airbus orders to save $1 billion through 2022

Since cases of the novel coronavirus began accelerating in March, U.S air travel demand has sunk by about 95%, forcing airlines to shift their focus from growth plans to parking planes and minimizing their daily cash burn. While the overall number of bookings was “extremely limited,” New York-based JetBlue said it believed demand had reached a floor around mid-April and it expected to have a better sense of the third and fourth quarters by early summer. Following measures to boost its liquidity, JetBlue expects its daily cash burn to fall to just below $10 million in May from …read more […]

No Picture
Trading Ideas

Square Dips as Quarterly Loss Almost Triples Due to Virus Pandemic

Shares in Square Inc. (SQ) depreciated 3.5% in pre-market U.S. trading after the payment processor saw its losses almost triple in the first quarter as the coronavirus pandemic triggered a decline in payment transactions by its business customers.Losses in the first quarter ballooned to $105.89 million, or 24 cents a share, from a loss of $38.15 million, or 9 cents a share, in the year-ago-period. Adjusted net loss per share amounted to 2 cents, versus earnings’ expectations of 13 cents during the same comparative period.Square’s stock slid 3.5% to $65.74 in pre-market U.S. trading after the company said it expected …read more […]

No Picture
Trading Ideas

Bombardier misses core profit estimates as pandemic delays jet deliveries

Business jet deliveries are expected to fall this year as the pandemic keeps people under a lockdown, disrupts global travel and slows down economic activity around the world. “Bombardier has begun the gradual resumption of manufacturing operations at both Aviation and Transportation necessary to deliver on our strong rail backlog and to continue the production ramp-up of the Global 7500,” Chief Executive Eric Martel said in a statement. The company said its aviation unit suffered a significant slowdown in orders in March, leading to a $13.6 billion business aircraft backlog at the end of the quarter. …read more […]

No Picture
Trading Ideas

Reap the Spoils of War

Here’s a fact we bet you haven’t heard.
It’s insane.
In all of World War II, the United States spent $4.7 trillion (in 2019 dollars). It used the money to build some incredible things… tanks, airplanes, monstrous ships and devious bombs.
The money went a long way. The innovations it led to are all around us.
But $4.7 trillion is a lot of money.
To give that amount of cash some context, if we spend $1 million per hour, all day, every day… it would take 576 years to spend what we did to win that war.
But check out this stat from The Washington Post…
All …read more […]